InsiderClue
← All stocks

Travere Therapeutics, Inc.

TVTX Mostly scheduled
CIK 0001438533 #1223 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$39.50M
$10.46M on a plan · $27.53M straight out of an exercise
Sold at will
$1.51M
8 of 86 sales
Net
−$39.50M
−$1.51M against sales at will

By person

16 insiders · 86 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Dube Eric M
CHIEF EXECUTIVE OFFICER
—
$15.95M (13) scheduled
−$15.95M
432,886
0.4592%
$29.47M
+19.6%
REED ELIZABETH E
Chief Legal Officer and GC
—
$4.93M (16) scheduled
−$4.93M
105,211
0.1116%
$7.16M
+31.3%
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
—
$3.86M (5) scheduled
−$3.86M
42,353
0.0449%
$2.88M
−18.6%
ROTE WILLIAM E.
Chief Research Officer
—
$3.29M (4) scheduled
−$3.29M
115,474
0.1225%
$7.86M
+33.0%
Baynes Roy D.
Director
—
$2.55M (6) scheduled
−$2.55M
41,500
0.0440%
$2.83M
+33.9%
Inrig Jula
CHIEF MEDICAL OFFICER
—
$2.37M (11) scheduled
−$2.37M
112,770
0.1196%
$7.68M
+82.0%
Meckler Jeffrey A
Director
—
$1.71M (5) scheduled
−$1.71M
91,500
0.0971%
$6.23M
+13.0%
Cline Christopher R.
CHIEF FINANCIAL OFFICER
—
$1.50M (11) scheduled
−$1.50M
118,016
0.1252%
$8.04M
+58.2%
Coughlin Timothy
Director
—
$1.27M (3) scheduled
−$1.27M
56,250
0.0597%
$3.83M
+14.8%
Heerma Peter
CHIEF COMMERCIAL OFFICER
—
$1.11M (6)
−$1.11M
140,684
0.1492%
$9.58M
+30.3%
LYONS GARY A
Director
—
$961.41K (6) scheduled
−$961.41K
61,500
0.0652%
$4.19M
+20.6%
Squarer Ron
Director
—
—
—
39,375
0.0418%
$2.68M
+36.4%
Orwin John A
Director
—
—
—
39,375
0.0418%
$2.68M
+36.4%
Poole Sandra
Director
—
—
—
34,000
0.0361%
$2.31M
+44.7%
Bruhn Suzanne Louise
Director
—
—
—
32,750
0.0347%
$2.23M
+47.2%
Williams Brinkley Ruth
Director
—
—
—
29,750
0.0316%
$2.03M
+54.5%

Individual transactions

41
Insider
Date
Role
Action
Shares
Price
Amount
Meckler Jeffrey A
10 Sep 2026
Director
Sold after exercise
3,100
$68.09
$211.07K
Meckler Jeffrey A
10 Sep 2026
Director
Sold after exercise
14,000
$67.46
$944.49K
Meckler Jeffrey A
10 Sep 2026
Director
Sold after exercise
1,200
$66.15
$79.38K
Meckler Jeffrey A
10 Sep 2026
Director
Sold after exercise
1,700
$65.39
$111.17K
LYONS GARY A
18 Aug 2026
Director
Sold after exercise
900
$63.86
$57.47K
LYONS GARY A
18 Aug 2026
Director
Sold after exercise
4,100
$63.27
$259.39K
LYONS GARY A
17 Aug 2026
Director
Sold after exercise
500
$64.16
$32.08K
LYONS GARY A
17 Aug 2026
Director
Sold after exercise
2,600
$63.50
$165.10K
LYONS GARY A
17 Aug 2026
Director
Sold after exercise
1,900
$62.53
$118.80K
Baynes Roy D.
12 Jun 2026
Director
Sold after exercise
4,500
$50.00
$225.00K
Coughlin Timothy
12 Jun 2026
Director
Sold after exercise
10,000
$50.07
$500.75K
Baynes Roy D.
5 May 2026
Director
Sold after exercise
4,500
$46.65
$209.93K
Inrig Jula
4 May 2026
CHIEF MEDICAL OFFICER
Sold after exercise
20,000
$45.00
$900.00K
REED ELIZABETH E
4 May 2026
Chief Legal Officer and GC
Sold after exercise
20,000
$45.00
$900.00K
Meckler Jeffrey A
4 May 2026
Director
Sold after exercise
8,000
$45.00
$360.00K
Baynes Roy D.
1 May 2026
Director
Sold after exercise
9,750
$44.22
$431.15K
REED ELIZABETH E
14 Apr 2026
Chief Legal Officer and GC
Sold after exercise
7,215
$41.93
$302.52K
REED ELIZABETH E
14 Apr 2026
Chief Legal Officer and GC
Sold after exercise
37,500
$41.07
$1.54M
Calvin Sandra
14 Apr 2026
SVP, CHIEF ACCOUNTING OFFICER
Sold after exercise
21,977
$41.07
$902.60K
Baynes Roy D.
14 Apr 2026
Director
Sold after exercise
6,750
$42.12
$284.31K
Baynes Roy D.
14 Apr 2026
Director
Sold after exercise
26,000
$41.07
$1.07M
LYONS GARY A
14 Apr 2026
Director
Sold after exercise
8,000
$41.07
$328.56K
Baynes Roy D.
6 Apr 2026
Director
Sold after exercise
10,000
$33.00
$330.00K
REED ELIZABETH E
1 Apr 2026
Chief Legal Officer and GC
Sold after exercise
10,000
$30.00
$300.00K
Dube Eric M
1 Apr 2026
CHIEF EXECUTIVE OFFICER
Sold after exercise
25,098
$31.46
$789.58K
Dube Eric M
1 Apr 2026
CHIEF EXECUTIVE OFFICER
Sold after exercise
34,902
$30.55
$1.07M
REED ELIZABETH E
16 Mar 2026
Chief Legal Officer and GC
Sold after exercise
10,000
$28.09
$280.86K
Dube Eric M
20 Feb 2026
CHIEF EXECUTIVE OFFICER
Sold after exercise
60,000
$30.10
$1.81M
REED ELIZABETH E
17 Feb 2026
Chief Legal Officer and GC
Sold after exercise
4,321
$28.26
$122.12K
REED ELIZABETH E
17 Feb 2026
Chief Legal Officer and GC
Sold after exercise
5,679
$27.50
$156.20K
Dube Eric M
27 Jan 2026
CHIEF EXECUTIVE OFFICER
Sold after exercise
51,865
$30.10
$1.56M
Dube Eric M
23 Jan 2026
CHIEF EXECUTIVE OFFICER
Sold after exercise
8,135
$30.01
$244.15K
REED ELIZABETH E
20 Jan 2026
Chief Legal Officer and GC
Sold after exercise
10,000
$27.34
$273.42K
Inrig Jula
24 Dec 2025
CHIEF MEDICAL OFFICER
Sold after exercise
15,000
$42.00
$630.00K
ROTE WILLIAM E.
24 Dec 2025
Chief Research Officer
Sold after exercise
60,000
$40.10
$2.41M
Cline Christopher R.
1 Dec 2025
CHIEF FINANCIAL OFFICER
Sold after exercise
20,000
$35.01
$700.20K
Calvin Sandra
4 Nov 2025
SVP, CHIEF ACCOUNTING OFFICER
Sold after exercise
67,115
$36.00
$2.42M
Coughlin Timothy
31 Oct 2025
Director
Sold after exercise
18,000
$35.03
$630.60K
Dube Eric M
29 Oct 2025
CHIEF EXECUTIVE OFFICER
Sold after exercise
27,128
$30.12
$817.07K
Dube Eric M
28 Oct 2025
CHIEF EXECUTIVE OFFICER
Sold after exercise
92,872
$30.38
$2.82M
REED ELIZABETH E
22 Sep 2025
Chief Legal Officer and GC
Sold after exercise
10,000
$25.00
$250.00K
Show all 86 transactions →

What was left out

Form 4 filings counted 67
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 37
Sales straight out of an exercise 41
Sales at will 8
Transactions with no price 0
Shares from compensation/vesting 1,207,247
History held since 2 Sep 2016